Gain Therapeutics
GANX
GANX
28 hedge funds and large institutions have $3.89M invested in Gain Therapeutics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
45% less capital invested
Capital invested by funds: $7.04M → $3.89M (-$3.15M)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$775K | |
| 2 | +$576K | |
| 3 | +$422K | |
| 4 |
CCC
Cable Car Capital
San Francisco,
California
|
+$186K |
| 5 |
Renaissance Technologies
New York
|
+$92.2K |
Top Sellers
| 1 | -$980K | |
| 2 | -$162K | |
| 3 | -$26.9K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$15.9K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$10.8K |